The present invention relates to the field of bioengineering, specifically to antibodies or their antigen-binding fragments, and to the use thereof. More particularly, the present invention relates to antibodies that bind specifically to CD47 and PD-L1. The invention also relates to a nucleic acid that codes for the given antibody or for the antigen-binding fragment thereof, to an expression vector, to a method of producing the antibody, and to a use of the aforementioned antibodies and compositions in cancer treatment.本發明涉及生物技術,尤其涉及抗體或其抗原結合片段及其用途。更具體而言,本發明涉及與CD47和PD-L1特異性結合的抗體。本發明還涉及編碼所述抗體或其抗原結合片段的核酸,表達載體,所述抗體的製備方法,以及所述抗體與組合物在癌症治療中的用途。